US5000957A
(en)
*
|
1984-03-19 |
1991-03-19 |
Alza Corporation |
Dispenser comprising hydrophilic osmopolymer
|
US4772474A
(en)
*
|
1985-08-09 |
1988-09-20 |
Alza Corporation |
Dispenser with internal arrangement of lamina means for dispensing beneficial agent
|
US4844984A
(en)
*
|
1984-03-19 |
1989-07-04 |
Alza Corporation |
Dispensing system with means for increasing delivery of beneficial agent from the system
|
US4756710A
(en)
*
|
1985-04-05 |
1988-07-12 |
Merck & Co., Inc. |
pH-Mediated drug delivery system
|
US4904475A
(en)
*
|
1985-05-03 |
1990-02-27 |
Alza Corporation |
Transdermal delivery of drugs from an aqueous reservoir
|
US4917676A
(en)
*
|
1986-11-20 |
1990-04-17 |
Ciba-Geigy Corporation |
User-activated transdermal therapeutic system
|
US5006342A
(en)
*
|
1986-12-22 |
1991-04-09 |
Cygnus Corporation |
Resilient transdermal drug delivery device
|
US4906463A
(en)
*
|
1986-12-22 |
1990-03-06 |
Cygnus Research Corporation |
Transdermal drug-delivery composition
|
AU607172B2
(en)
*
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
US4911707A
(en)
*
|
1987-02-13 |
1990-03-27 |
Ciba-Geigy Corporation |
Monolithic user-activated transdermal therapeutic system
|
US4788062A
(en)
*
|
1987-02-26 |
1988-11-29 |
Alza Corporation |
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
|
US5080646A
(en)
*
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
GB8804164D0
(en)
*
|
1988-02-23 |
1988-03-23 |
Tucker J M |
Bandage for administering physiologically active compound
|
GB2232892B
(en)
*
|
1988-02-23 |
1991-07-24 |
John Mark Tucker |
Occlusive body for administering a physiologically active substance
|
US5169382A
(en)
*
|
1988-10-03 |
1992-12-08 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
DE3844247A1
(de)
*
|
1988-12-29 |
1990-07-12 |
Minnesota Mining & Mfg |
Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments
|
DE69026323T2
(de)
*
|
1989-02-06 |
1996-10-24 |
Hisamitsu Pharmaceutical Co |
Schnittstelle für iontophorese
|
DE3905051A1
(de)
*
|
1989-02-18 |
1990-08-30 |
Lohmann Therapie Syst Lts |
Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)
|
US5096715A
(en)
*
|
1989-11-20 |
1992-03-17 |
Alko Ltd. |
Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
|
US5462744A
(en)
*
|
1989-12-01 |
1995-10-31 |
Boehringer Ingelheim Kg |
Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
|
DE3939703C2
(de)
*
|
1989-12-01 |
1998-07-02 |
Boehringer Ingelheim Kg |
Verbesserte transdermale Applikation von pharmakologisch aktiven Verbindungen
|
ES2082973T3
(es)
*
|
1990-03-30 |
1996-04-01 |
Alza Corp |
Dispositivo para administracion iontoforetica de farmacos.
|
US5149719A
(en)
*
|
1990-04-27 |
1992-09-22 |
Minnesota Mining And Manufacturing Company |
Composition for transdermal penetration of medicaments
|
US5512292A
(en)
*
|
1990-10-29 |
1996-04-30 |
Alza Corporation |
Transdermal contraceptive formulations methods and devices
|
US5164190A
(en)
*
|
1990-12-11 |
1992-11-17 |
Theratech, Inc. |
Subsaturated transdermal drug delivery device exhibiting enhanced drug flux
|
ZA928011B
(en)
*
|
1991-10-18 |
1993-06-23 |
Alza Corp |
Transdermal administration of melatonin.
|
WO1993023025A1
(en)
*
|
1992-05-13 |
1993-11-25 |
Alza Corporation |
Transdermal administration of oxybutynin
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
US5607691A
(en)
*
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
DE4308649C2
(de)
*
|
1993-03-18 |
1995-11-16 |
Lohmann Gmbh & Co Kg |
Medizinisches Pflastermaterial sowie Verfahren zu seiner Herstellung und dessen Verwendung
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
AU7396294A
(en)
*
|
1993-06-25 |
1995-01-24 |
Alza Corporation |
Incorporating poly-n-vinyl amide in a transdermal system
|
EP0721348B1
(en)
*
|
1993-09-29 |
1999-09-01 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer
|
US5466465A
(en)
*
|
1993-12-30 |
1995-11-14 |
Harrogate Holdings, Limited |
Transdermal drug delivery system
|
US5762955A
(en)
|
1994-02-04 |
1998-06-09 |
Smith; Stephen Jay |
Method for application and maintenance of medication on body tissue
|
US5503843A
(en)
*
|
1994-04-22 |
1996-04-02 |
Flora Inc. |
Transdermal delivery of alpha adrenoceptor blocking agents
|
US5498417A
(en)
*
|
1994-05-12 |
1996-03-12 |
Coating Sciences, Inc. |
Transdermal delivery of appetite suppressant drug
|
DE4423850A1
(de)
*
|
1994-07-07 |
1996-01-11 |
Labtec Gmbh |
Transdermales therapeutisches System zur Applikation von Naloxon
|
US5861439A
(en)
*
|
1994-11-14 |
1999-01-19 |
Alza Corporation |
Method for enhanced electrotransport agent delivery
|
US5562917A
(en)
*
|
1994-12-23 |
1996-10-08 |
Pentech Pharmaceuticals, Inc. |
Transdermal administration of apomorphine
|
FR2732896B1
(fr)
*
|
1995-04-11 |
1997-06-13 |
Prographarm Lab |
Forme pharmaceutique transdermique pour l'administration percutanee de l'apomorphine
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US5840327A
(en)
*
|
1995-08-21 |
1998-11-24 |
Alza Corporation |
Transdermal drug delivery device having enhanced adhesion
|
US5730721A
(en)
*
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
SE9601528D0
(sv)
*
|
1996-04-23 |
1996-04-23 |
Pharmacia Ab |
Transdermally administered dextromethorphan as antitissue agent
|
US6512010B1
(en)
*
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US5985317A
(en)
*
|
1996-09-06 |
1999-11-16 |
Theratech, Inc. |
Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
|
ATE229817T1
(de)
*
|
1996-10-24 |
2003-01-15 |
Alza Corp |
Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
US7150881B2
(en)
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
WO1999032153A1
(en)
|
1997-12-22 |
1999-07-01 |
Alza Corporation |
Monoglyceride and ethyl palmitate permeation enhancer compositions
|
US6096943A
(en)
*
|
1998-01-09 |
2000-08-01 |
Maiwald; Diane C |
Skin wound protector
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
PT1140039E
(pt)
|
1998-12-18 |
2010-02-03 |
Alza Corp |
Dispositivos transparentes de administração transdérmica de nicotina
|
EP2305324B1
(en)
*
|
1999-03-25 |
2014-09-17 |
Metabolix, Inc. |
Medical devices and applications of polyhydroxyalkanoate polymers
|
EP1169025B1
(en)
*
|
1999-04-01 |
2005-08-24 |
Alza Corporation |
Transdermal drug delivery devices comprising a polyurethane drug reservoir
|
US6696078B1
(en)
*
|
1999-07-21 |
2004-02-24 |
Edwin J. Masters |
System and methods for local intradermal treatment
|
AU780953B2
(en)
|
1999-08-30 |
2005-04-28 |
Tepha, Inc. |
Flushable disposable polymeric products
|
US6495229B1
(en)
*
|
1999-09-17 |
2002-12-17 |
Avery Dennison Corporation |
Pattern coated adhesive article
|
JP4358978B2
(ja)
*
|
2000-09-05 |
2009-11-04 |
日東電工株式会社 |
経皮吸収製剤
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
JP4489356B2
(ja)
*
|
2001-05-11 |
2010-06-23 |
メリオン リサーチ スリー リミテッド |
浸透促進剤
|
DE10141651B4
(de)
*
|
2001-08-24 |
2007-02-15 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
JP4199485B2
(ja)
*
|
2002-06-07 |
2008-12-17 |
久光製薬株式会社 |
貼付剤
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
ATE461681T1
(de)
*
|
2003-04-29 |
2010-04-15 |
Gen Hospital Corp |
Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
|
US8034270B2
(en)
|
2003-05-08 |
2011-10-11 |
Tepha, Inc. |
Polyhydroxyalkanoate medical textiles and fibers
|
EP1651273B1
(en)
*
|
2003-07-08 |
2012-08-29 |
Tepha, Inc. |
Poly-4-hydroxybutyrate matrices for sustained drug delivery
|
JP2007503221A
(ja)
*
|
2003-08-22 |
2007-02-22 |
テファ, インコーポレイテッド |
ポリヒドロキシアルカノエート神経再生デバイス
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US8741332B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for dermally treating neuropathic pain
|
US20070196452A1
(en)
*
|
2004-06-07 |
2007-08-23 |
Jie Zhang |
Flux-enabling compositions and methods for dermal delivery of drugs
|
US8907153B2
(en)
|
2004-06-07 |
2014-12-09 |
Nuvo Research Inc. |
Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
|
US8741333B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for treating dermatitis or psoriasis
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
PT1778305E
(pt)
*
|
2004-08-03 |
2010-07-27 |
Tepha Inc |
Suturas de poli-hidroxialcanoato que no se enrolam
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
PL1814531T3
(pl)
|
2004-10-21 |
2010-11-30 |
Durect Corp |
Transdermalne systemy dostarczania
|
DE602006016915D1
(de)
*
|
2005-01-28 |
2010-10-28 |
Tepha Inc |
Embolisierung unter verwendung von poly-4-hydroxybutyrat-partikeln
|
US20060223786A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Smith David J |
Transdermal pain control method and device
|
JP2007175116A
(ja)
*
|
2005-12-27 |
2007-07-12 |
Hisamitsu Pharmaceut Co Inc |
イオントフォレーシス装置及びその製造方法
|
JP2007175117A
(ja)
*
|
2005-12-27 |
2007-07-12 |
Hisamitsu Pharmaceut Co Inc |
イオントフォレーシス装置及びその製造方法
|
WO2007121188A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
US20070248657A1
(en)
*
|
2006-04-25 |
2007-10-25 |
Smith David J |
Multi-compartment transdermal pain control device
|
US20070280972A1
(en)
*
|
2006-04-25 |
2007-12-06 |
Zars, Inc. |
Adhesive solid gel-forming formulations for dermal drug delivery
|
EP3357490A1
(en)
|
2006-04-28 |
2018-08-08 |
Children's Hospital Medical Center |
Fusogenic properties of saposin c and related proteins and polypeptides for application to transmembrane drug delivery systems
|
AU2007253899A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Knopp Neurosciences, Inc. |
Compositions of R(+) and S(-) pramipexole and methods of using the same
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
RU2454409C2
(ru)
|
2007-03-14 |
2012-06-27 |
Нопп Ньюросайенсиз, Инк. |
Синтез хирально очищенных замещенных бензотиазолдиаминов
|
WO2009046155A1
(en)
*
|
2007-10-01 |
2009-04-09 |
Michael Adams G |
Dressing, method and kit for skin crack repair
|
EP2259780A2
(en)
*
|
2008-02-28 |
2010-12-15 |
Syntropharma Limited |
Pharmaceutical composition comprising naltrexone
|
CA2734491A1
(en)
*
|
2008-08-19 |
2010-02-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (r)-pramipexole
|
US20100221313A1
(en)
*
|
2008-12-01 |
2010-09-02 |
Innovative Pharmaceuticals, Llc |
Transdermal reservoir patch
|
AU2010262970A1
(en)
*
|
2009-06-19 |
2012-01-12 |
Knopp Neurosciences, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
WO2011130455A1
(en)
|
2010-04-13 |
2011-10-20 |
Najib Babul |
Dermal pharmaceutical compositions of 1-methyl-2',6'-pipecoloxylidide and method of use
|
EP2654638A4
(en)
*
|
2010-12-20 |
2014-07-02 |
Polytherapeutics Inc |
COMPOSITION FOR TRANSDERMAL ADMINISTRATION OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG
|
AU2012205791B2
(en)
|
2011-01-10 |
2016-11-03 |
Invion, Ltd. |
Use of beta-adrenergic inverse agonists for smoking cessation
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
US9682068B2
(en)
|
2013-05-20 |
2017-06-20 |
Mylan Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
CN105764507B
(zh)
|
2013-07-12 |
2019-07-19 |
诺普生物科学有限责任公司 |
治疗升高的嗜酸性粒细胞和/或嗜碱性粒细胞的水平
|
AU2014306683B2
(en)
|
2013-08-13 |
2017-10-12 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
|
ES2871556T3
(es)
|
2013-08-13 |
2021-10-29 |
Knopp Biosciences Llc |
Composiciones y métodos para el tratamiento de la urticaria crónica
|
EP3180040B1
(en)
|
2014-08-15 |
2020-05-13 |
Tepha, Inc. |
Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
|
EP3230500A1
(en)
|
2014-12-11 |
2017-10-18 |
Tepha, Inc. |
Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|